| NCT ID | NCT06253013 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Health Network, Toronto |
| Condition | Chronic Obstructive Pulmonary Disease |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2023-09-15 |
| Primary Completion | 2027-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2023-09-15 with a primary completion date of 2027-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The investigators' goal for this project is to evaluate the feasibility, acceptability, and actual usage of a program of care for patients with COPD recently discharged after an acute exacerbation. The program of care includes virtual pulmonary rehabilitation, integrated care, and remote clinical monitoring.
Eligibility Criteria
Inclusion Criteria: * Referred to either Virtual Pulmonary Rehabilitation or Remote Clinical Monitoring at Toronto Grace Health Centre after discharge from UHN hospital with an AECOPD as defined by the clinical team Exclusion Criteria: * Pulmonary condition other than COPD as the main respiratory disease such as bronchiectasis or asthma * Projected life expectancy ≤ 2 months , as determined by the clinical team * Significant cognitive impairment and absence/inability of a family caregiver to consent and to follow study processes
Contact & Investigator
Robert Wu, MD
PRINCIPAL INVESTIGATOR
University Health Network, Toronto
Frequently Asked Questions
Who can join the NCT06253013 clinical trial?
This trial is open to participants of all sexes, aged 40 Years or older, studying Chronic Obstructive Pulmonary Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06253013 currently recruiting?
Yes, NCT06253013 is actively recruiting participants. Contact the research team at alice.tu2@uhn.ca for enrollment information.
Where is the NCT06253013 trial being conducted?
This trial is being conducted at Toronto, Canada.
Who is sponsoring the NCT06253013 clinical trial?
NCT06253013 is sponsored by University Health Network, Toronto. The principal investigator is Robert Wu, MD at University Health Network, Toronto. The trial plans to enroll 100 participants.